FDA Updates Templates for Serology Test EUA Requests
The updates clarify FDA’s previous recommendations for demonstrating clinical performance and presenting validation data and provide new recommendations.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Compliance, Covid 19 |
The updates clarify FDA’s previous recommendations for demonstrating clinical performance and presenting validation data and provide new recommendations.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The SARS-CoV-2 antibodies are being sourced by diagnostic developers for applications such as lateral flow assays and ELISAs.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The model-building program is open access and can be found from the home page of Charmm-GUI, a program that simulates complex biomolecular systems.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The nucleic acid assay is for the qualitative detection of SARS-CoV-2 nucleic acids in respiratory samples from individuals who are suspected of covid-19.
Read MorePosted by Laurie Bonner | Jun 25, 2020 | Covid 19 |
The action is an effort to help protect public health from fraudulent products.
Read More